Joshua Omale, Pediatric Oncology Advocate, Innovation Council Member at Coalition Against Childhood Cancer (CAC2), shared a post on LinkedIn:
“CHAPTER 3
The Distance between Discovery and Survival : Why every Innovation has two Birthplaces
Every scientific breakthrough is born twice.
The first birth happens in a laboratory.
- A discovery is made.
- A gene is identified.
- A biomarker is validated.
- A medicine is developed.
- A diagnostic platform is engineered.
- Knowledge advances.
But there is a second birth that receives far less attention. The moment that same discovery changes the outcome of a child.
Only then has innovation completed its journey.
Perhaps one of the greatest misconceptions in global health is that discovery and impact are separated only by time.
They are not.
They are separated by translation.
Between every laboratory breakthrough and every surviving child exists an invisible pathway.
It is built through regulation.
- Diagnostics.
- Manufacturing.
- Supply chains.
- Health financing.
- Clinical training.
- Data systems.
- Community trust.
- Public policy.
- Implementation.
- Partnership
When even one of these links fails, remarkable science can remain remarkably distant from the people who need it most.
We often celebrate the publication of scientific breakthroughs. Perhaps we should celebrate something even more profound:
The moment those breakthroughs become ordinary clinical practice for every child, regardless of geography.
A targeted therapy developed in Boston. A genomic sequencing platform validated in Cambridge. An AI diagnostic model trained in Seoul.
None of these innovations achieve their highest purpose simply because they exist.
They achieve it when a child in Jos, Kigali, Lusaka, or Freetown survives because they were no longer beyond reach.
This is why I believe Africa’s greatest innovation challenge is no longer discovery alone.
It is translation. Not translating languages. Translating knowledge into access. Research into policy. Technology into routine care.
Scientific possibility into population health. Innovation into survival.
The future will undoubtedly bring extraordinary advances in molecular biology, genomics, immunology, pharmacology, artificial intelligence, and precision medicine.
The defining question, however, will not be how rapidly science advances. It will be how deliberately we build systems capable of carrying those advances to every child who needs them.
Because scientific discovery is only the beginning of innovation. Its destination has always been human life. And the true measure of progress is not what we invent. It is who survives because of it.
Joshua Omale
Building at the intersection of science, systems, and leadership for the future of children’s health in Africa.”
Other articles featuring Joshua Omale on OncoDaily.